
Wessel stated that he was very familiar with Pfizer’s legal team and handled product liability for the company during his tenure as Assistant General Counsel. He cited the strong relationship between Pfizer and DLA Piper and his familiarity with both organizations. Wessel left Pfizer in 2008 for King & Spaulding, which declined to comment on today’s move.




